Kairos Pharma (KAPA) will implement a one-for-seven reverse stock split of its outstanding shares on Sept. 1, the company said late Friday.
The stock split is aimed at reducing the number of outstanding shares and raising the per-share trading price to maintain compliance for continued listing on the NYSE American, the company said.